BioHarvest Sciences (BHST) Financial Statements

41 Followers

BioHarvest Sciences Financial Overview

BioHarvest Sciences's market cap is currently $87.50M. The company's EPS TTM is $-0.62; its P/E ratio is -9.31; BioHarvest Sciences is scheduled to report earnings on May 14, 2026, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	$ 34.51M	$ 25.19M	$ 12.67M	$ 5.50M	$ 2.10M
Gross Profit	$ 20.48M	$ 13.94M	$ 5.63M	$ 1.22M	$ 670.00K
Operating Income	$ -5.58M	$ -6.99M	$ -9.97M	$ -10.61M	$ -8.49M
EBITDA	$ -6.71M	$ -9.72M	$ -9.76M	$ -9.13M	$ -8.64M
Net Income	$ -11.13M	$ -12.91M	$ -12.56M	$ -11.24M	$ -9.83M
Balance Sheet
Cash & Short-Term Investments	$ 23.02M	$ 2.39M	$ 5.36M	$ 1.74M	$ 4.12M
Total Assets	$ 47.66M	$ 25.00M	$ 15.00M	$ 9.39M	$ 10.21M
Total Debt	$ 14.10M	$ 13.82M	$ 22.34M	$ 10.56M	$ 2.66M
Net Debt	$ -8.92M	$ 11.43M	$ 16.98M	$ 8.82M	$ -1.46M
Total Liabilities	$ 22.22M	$ 23.67M	$ 29.86M	$ 15.32M	$ 7.35M
Stockholders' Equity	$ 25.45M	$ 1.33M	$ -14.85M	$ -5.93M	$ 2.85M
Cash Flow
Free Cash Flow	$ -9.58M	$ -9.52M	$ -10.00M	$ -10.50M	$ -8.43M
Operating Cash Flow	$ -7.23M	$ -6.68M	$ -8.52M	$ -9.24M	$ -6.79M
Investing Cash Flow	$ -2.37M	$ -3.03M	$ -1.47M	$ -1.26M	$ -1.64M
Financing Cash Flow	$ 30.19M	$ 6.78M	$ 13.56M	$ 8.14M	$ 10.77M

Currency in USD

BioHarvest Sciences Earnings and Revenue History

Income Statement >

BioHarvest Sciences Debt to Assets

Balance Sheet >

BioHarvest Sciences Cash Flow

Cash Flow >

BioHarvest Sciences Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >